ArticleDermatology and therapy2023

Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.

Alan MenterPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.